Drug
Bevacizumab AS Myl 1402o
Bevacizumab AS Myl 1402o: highest development phase Phase 3, developed by Viatris. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Viatris
Trials
| Drug | Phase | Indication |
|---|---|---|
| Bevacizumab as MYL-1402O NCT04633564 | Phase 3 | NSCLC Stage IV |
Latest
No recent events.
Follow Bevacizumab AS Myl 1402o on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.